Unknown

Dataset Information

0

Disturbance of lysosomal glycogen metabolism by liposomal anti-alpha-glucosidase and some anti-inflammatory drugs.


ABSTRACT: The size-distribution of liver glycogen was shown to be distinctly affected by the anti-inflammatory drugs salicylate and indomethacin. By measurement of the incorporation of radioactive glucose into glycogen, salicylate was shown to have a depressing effect on overall liver glycogen metabolism. These effects appear to arise from the stabilizing of the lysosome by the drugs. The incorporation, via liposomes, of purified anti-1,4-alpha-glucosidase activity and in the content of high-molecular-weight glycogen. These changes are increased by prolonged liposomal antibody treatment and suggest that a possible feedback control mechanism operates in the incorporation of glycogen into lysosomes. These experiments may be useful as a model of glycogen turnover and its failure in glycogenosis type II (Pompe's disease).

SUBMITTER: Geddes R 

PROVIDER: S-EPMC1152015 | biostudies-other | 1983 Apr

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC3687018 | biostudies-literature
| S-EPMC1144989 | biostudies-other
| S-EPMC1149727 | biostudies-other
| S-EPMC1163990 | biostudies-other
| S-EPMC7156451 | biostudies-literature
| S-EPMC1184687 | biostudies-other
| S-EPMC8477953 | biostudies-literature
| S-EPMC1132229 | biostudies-other
| S-EPMC4103853 | biostudies-literature
| S-EPMC7357040 | biostudies-literature